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Abstract
Background: Heart rate variability (HRV) has been used to assess cardiac autonomic
activity in critically ill patients, driven by translational and biomarker research
agendas. Several clinical and technical factors can interfere with the measurement
and/or interpretation of HRV. We systematically evaluated how HRV parameters are
acquired/processed in critical care medicine.
Methods: PubMed, MEDLINE, EMBASE and the Cochrane Central Register of
Controlled Trials (1996–2016) were searched for cohort or case–control clinical
studies of adult (>18 years) critically ill patients using heart variability analysis.
Duplicate independent review and data abstraction. Study quality was assessed using
two independent approaches: Newcastle–Ottowa scale and Downs and Black
instrument. Conduct of studies was assessed in three categories: (1) study design and
objectives, (2) procedures for measurement, processing and reporting of HRV, and (3)
reporting of relevant confounding factors.
Results: Our search identified 31/271 eligible studies that enrolled 2090 critically
ill patients. A minority of studies (15; 48%) reported both frequency and time
domain HRV data, with non-normally distributed, wide ranges of values that
were indistinguishable from other (non-critically ill) disease states. Significant
heterogeneity in HRV measurement protocols was observed between studies;
lack of adjustment for various confounders known to affect cardiac autonomic
regulation was common. Comparator groups were often omitted (n = 12; 39%).
This precluded meaningful meta-analysis.
Conclusions: Marked differences in methodology prevent meaningful
comparisons of HRV parameters between studies. A standardised set of
consensus criteria relevant to critical care medicine are required to exploit
advances in translational autonomic physiology.
Keywords: Autonomic, Heart rate variability, Human, Systematic review
Background
Autonomic changes are evident from the onset of acute pathology requiring critical
care. Cardiac autonomic function can be derived by analysing variability between heart
beats to yield time domain and frequency domain (power spectral density) measures
that reflect autonomic modulation of cardiac frequency [1, 2]. Heart rate variability
(HRV) appears to contribute diagnostic and prognostic value in various cardiometa-
bolic conditions associated with subclinical autonomic dysfunction that predispose to
critical illness including hypertension, coronary artery disease, heart failure and
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diabetes [3–7]. Similarly, HRV has been proposed to serve as a potential diagnostic and
prognostic tool in critically ill patients [8].
However, HRV measures in critically ill patients are fraught with potential problems.
[9] Although population norms for HRV parameters have been reported in healthy
populations [10], the impact of multiple physiological, procedural and technical factors
in critically ill patients has not undergone systematic scrutiny in critical care medicine
[11]. Moreover, the validity of HRV as a tool to interrogate autonomic function is in-
creasingly under physiological scrutiny [12, 13], since a strong correlation between
HRV and morbidity/mortality appears to be largely attributable to incident heart rate.
In addition, recording technique, clinical context and adjustment for incident heart rate
are key factors to consider when interpreting the translational relevance of HRV in crit-
ically ill patients.
Here, we sought to systematically evaluate the methodology and design of HRV stud-
ies in critical care medicine. We focused on whether recommended standards for meas-
urement and reporting have been employed [14, 15], with the aim of identifying areas
to refine in future HRV experimental design in critical care medicine.
Methods
Identification of studies
A literature review was performed based on the Preferred Reporting Items for Systematic
reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews [16]. The sum-
mary of the search strategy employed is shown in Additional file 1.
We searched the electronic databases PubMed, EMBASE, MEDLINE and the
Cochrane Central Register of Controlled Clinical Trials for articles investigating HRV
measurement in intensive care patients. Inclusion criteria were full-text studies written
in English involving adult patients, published after 1996 (following published guide-
lines) and reporting traditional time and frequency domain parameters [15]. Studies
which reported newer analysis techniques of HRV (e.g. entropy analysis) were excluded,
as we focussed on those reporting measures in line with recent European guidance
[17]. The following Medical Subject Headings (MESH) were used to identify pertinent
articles: “Heart rate variability OR HRV AND Sepsis”, “Heart rate variability OR HRV
AND multiple organ dysfunction OR MODS”, “Heart rate variability OR HRV AND
critical illness”, “Heart rate variability OR HRV AND intensive care OR ICU”. The last
search took place on 9 November 2016. We screened articles by title search and ab-
stract review. Relevant articles were analysed for eligibility, and further articles were
identified from reference lists. Articles were excluded based on the following criteria:
experimental studies, incorrect target population (adult; >18 years old), medical field
other than intensive care, not original research, topic not within scope or traditional
HRV parameters not reported.
Data extraction
Data was extracted by two independent reviewers (S.K and A.S) and recorded into a
standardised excel sheet recording: author, year of publication, study design, number of
subjects, mean patient age, proportion of male subjects, risk stratification score, com-
parator groups, study aim and outcome, study design, protocol for measurement, pro-
cessing, analysis and reporting of HRV parameters, adjustment and reporting of
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confounding factors and quality assessment. We identified the following clinical con-
founding factors: age, gender, average heart rate, average respiratory rate, co-
morbidities, drugs, sedative drugs, vasoactive drugs, enteral nutrition and mechanical
ventilation. Full details of the impact on HRV of these parameters are provided in
Additional file 1. For reporting and analysis purposes, we selected the most commonly
used time and frequency domain HRV parameters [15].
Risk of bias and study quality assessment
The quality of studies was assessed by two assessors independently (SK, SM) using
two established tools (Newcastle–Ottowa scale, Downs and Black Instrument). The
Downs and Black instrument is recommended by the Cochrane Collaboration for
use in non-randomised and observational studies (Additional file 1) [18, 19]. Inter-
observer reliability evaluating quality within five domains: reporting, external valid-
ity, bias, confounding and power. Five questions were omitted because they are de-
signed for interventional trials. The version which we employed in this study
therefore has a maximum score of 22. Differences between reviewers were resolved




We identified 238 studies which underwent screening by title search and abstract re-
view. From these, 31 articles involving 2090 patients (including controls) met the inclu-
sion criteria for assessing the role of HRV in critically ill patients [20–53]. Two articles
analysed the same cohort of patients [34, 37].
Study characteristics
Demographic and clinical data, including comparator groups are summarised in Table 1.
All articles reported cohort or case–control studies. The average age of patients
was 60 ± 7 years. The majority of studies (22/31; 71%) explored the association be-
tween HRV measures, morbidity and mortality. Key clinical findings from these
studies are summarised in Table 2. Due to significant differences in trial design,
methodology, confounding, non-standardised comparator groups and inconsistent
reporting of summary data, a meta-analysis could not be performed. However,
there was consistency between studies in their findings that LF/HF ratio was in-
versely associated with increased disease severity or mortality. For illustrative pur-
poses, the individual effect sizes across six studies reporting mean and standard
deviation data looking at disease severity and mortality using the most commonly
reported HRV parameter (LF/HF ratio) are shown (Fig. 1).
Quality of studies
No studies reported Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) guidelines. Two studies analysed data retrospectively. A mi-
nority of studies (n = 5; 16%) used individualised HRV data—i.e. patients serving as
their own control, prior to an intervention. More than one third of studies (n = 13;
42%) did not describe any comparator group. The remainder of studies used non-age
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Table 1 Demographics and study design of studies
Reference number.
author
Year Study design Study populations
(± comparator group)
Patients (n) Age (mean ± SD or mean [range]) Male
(%)
20. Annane 1999 Case–control Sepsis (healthy controls) 26 Septic shock 52 ± 14
Sepsis 54 ± 17
Control 43 ± 11
65
21. Korach 2001 Cohort Sepsis 41 50 [20–90] 44
22. Barnaby 2002 Cohort Sepsis 15 59 [39–85] –
23. Pontet 2003 Case–control Sepsis + MODS
(Sepsis −MODS)
22 MODS 59.5 ± 17.8
Non-MODS 60 ± 10.4
64
24.Shen 2003 Cohort Weaning 24 Successful wean 76 ± 12.9
Unsuccessful wean 69.8 ± 17.8
42
25. Schmidt 2005 Cohort MODS
(literature values)
85 60.4 ± 14 62
26. Papaioannou 2006 Cohort MODS 53 63.02 ± 14.68 58
44. Bourgault 2006 Cohort Mixed aetiology 18 60 [33–82] 72
45. Chen 2007 Cohort Sepsis 81 67 [30–84] 41
50. Passariello 2007 Case–control Ischaemic sudden death 40 Sudden death 66 ± 8
Pathology matched controls
68 ± 8
46. Chen 2008 Cohort Sepsis 132 67 [27–86] 47
47. Aboab 2008 Case–control Sepsis ± adrenal
insufficiency
(healthy controls)
81 Septic shock and adrenal failure
55 ± 16
Septic shock 58 ± 19
Healthy controls (not provided)
36
27. Nogueira 2008 Cohort Sepsis 31 Survivors 44.9 ± 5.9
Non-survivors 55.6 ± 4.63
74
28. Papaioannou 2009 Cohort Sepsis
(Sepsis SOFA <10)
45 57.8 –
51. Tiainen 2009 Cohort Out of hospital cardiac
arrest
70 Hypothermia 60 (23–75)
Normothermia 59 (18–75)
86
29. Schmidt 2010 Case–controla MODS 178 61.1 ± 13.2 67
30. Kasaoka 2010 Cohort SIRS 10 53 ± 15 70




210 Out of hospital cardiac arrest
68 ± 10
Severe sepsis and mechanical
ventilation 66 ± 8
Severe sepsis 68 ± 7
Sepsis 67 ± 6
Healthy 66 ± 6
55
32.Gomez Duque 2012 Cohort Sepsis
(literature values)
100 55 [18–88] 42
33. Brown 2013 Cohort Sepsis 48 57 [40–63] 46
34. Green 2013 Cohort MODS 33 56.5 ± 15.9 61
35.Wieske 2013 Cohort ICU acquired weakness 83 ICU acquired weakness 60 ± 13
No ICU acquired weakness
59 ± 16
60
36. Wieske 2013 Cohort Mixed aetiology
(healthy controls)
32 Patients 54 ± 15
Healthy control 36 ± 2
70
37. Bradley 2013 Cohort Mixed aetiology 33 56.5 ± 15.9 61
38. Huang 2014 Cohort Mixed aetiology 101 Successful 65 ± 18
Unsuccessful 71 ± 16
65
39. Zhang 2014 Cohort SIRS/MODS
(non-MODS)
41 47 [34–59] 54
40. Schmidt 2014 Case–controla CCF and MODS
(literature values)
130 CCF 63 ± 10.1
MODS 62.8 ± 10.2
63
52. Tang 2014 Case–control Stroke 227 AF stroke 74 ± 12
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matched healthy volunteers, non-critically ill patients with established cardiovascular
disease or HRV values derived from the literature. External validity (as adjudged by the
Down and Black assessment tool) was poor, with the majority of studies achieving a
score of 1.
Risk of bias assessment
We found recurring potential sources of bias in study design, with 19 (61%) studies fail-
ing to report whether HRV data analysers were masked to the patient condition/out-
come (Additional file 1). Only one study performed a power calculation [41].
Data acquisition and preparation
Details on short-term recordings, including source of heart rate periods [54, 55],
duration of recordings, epochs used for analysis and patient position [56] were
variable or not reported. Fourteen (45%) studies did not describe the sampling fre-
quency of recordings; four (13%) studies used sampling rates below the recom-
mended 250 Hz [15].
ECG recording in the critically ill population is frequently contaminated by electrical
and physiological artefacts. Thus, detailing methods to detect artefact (manual or auto-
mated) and its management (segment selection, deletion or interpolation) is important
for data interpretation [57]. Fourteen (45%) studies reported automated and/or manual
editing of the raw ECG to remove artefact by replacing the missing data with cubic
spline or linear interpolation methods. In keeping with guidelines, the majority of stud-
ies used interpolation methods as opposed to deletion of abnormal beats to avoid a loss
of information [15].
HRV analysis
Measurement protocols, processing and reporting of HRV data are summarised in
Table 3.
A minority of studies (14; 45%) reported both frequency and time domain data
(Table 3). A minority of studies (9; 29%) reported frequency data in normalised units
together with absolute values, in keeping with established recommendations. Summary
values for commonly reported HRV parameters revealed a wide range of non-normally
distributed data for each (Additional file 1: Table S3). Reporting and/or adjustment for
heart rate and respiratory rate, which dramatically alter both high and low frequency
spectral components [58] was inconsistent between studies. A small majority of studies
(17; 55%) reported average heart rate, whilst a minority (6; 19%) adjusted for, or re-
ported, respiratory rate during data acquisition.
Table 1 Demographics and study design of studies (Continued)
41. Zaal 2015 Case–control ICU delirium
(no delirium)
25 ICU delirium 67 ± 12
No ICU delirium 57 ± 16
72
42. Hammash 2015 Cohort Weaning 35 53.3 ± 14.6 66
53. Nagaraj 2016 Case seriesa Not specified 40 56.3 ± 16.8 62.5
Reference for each paper is shown before first author (first column)
CCF congestive cardiac failure, MODS multiple organ dysfunction syndrome, SIRS systemic inflammatory response
syndrome, SOFA sequential organ failure assessment
aRetrospective analysis
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Table 2 Study objectives and key findings
Author Year Study objectives Key findings
Annane 1999 Compare HRV between sepsis, septic
shock and healthy volunteers
TP, LF, LFnu, LF/HF lower in septic
shock vs sepsis
Korach 2001 Effects of sepsis, age, sedation,
catecholamines and illness severity
on sympathovagal balance (LF/HF)
LF/HF ratio <1.5 was associated with
sepsis and mortality
Barnaby 2002 Assess if HRV can predict sepsis severity Negative correlation between LFnu,
LF/HF and SOFA score
Pontet 2003 Assess if HRV can predict MODS in sepsis Low LF and RMSSD associated with
MODS
Shen 2003 Assess changes in cardiac autonomic
activity during weaning from
mechanical ventilation
HF, LF and TP decreased in
unsuccessful group during
spontaneous breathing trial
Schmidt 2005 Effects of MODS, age, sedation,
catecholamines, mechanical ventilation
on HRV
Assess if HRV can predict mortality in
MODS
Time and frequency domain reduced
in MODS
HRV indices affected by mechanical
ventilation but not age, sedation or
catecholamines
LnVLF associated with 28-day survival.
Papaioannou 2006 Assess if HRV associated with disease
severity and mortality
LF/HF ratio negatively correlated
with SOFA score
Bourgault 2006 Effects of endotracheal suction on HRV No significant differences found in
HRV indices between closed or open
suctioning
Chen 2007 Assess if HRV can predict sepsis severity Septic shock associated lower LF,
LFnu, LF/HF, and higher RMSSD, HF,
HFnu
Passariello 2007 Assess if HRV can predict ischaemic
sudden cardiac death
SDNN decreases shortly before
ischaemic sudden death
Chen 2008 Assess if HRV can predict 28-day
mortality
Low SDNN, TP, VLF, LF and LF/HF
associated with increased 28-day
mortality
Aboab 2008 Assess effect of steroids on HRV in
patients with sepsis
LF, LFnu, LF/HF lower in septic shock.
Corticosteroids helped increase LFnu
values in adrenal insufficiency group.
Nogueira 2008 Assess relationship between HRV,
markers of myocardial damage and
free fatty acids in sepsis
Low LF, HF and LF/HF associated with
mortality
Papaioannou 2009 Assess relationship between HRV and
biomarkers of inflammation (CRP, IL-6,
IL-10) in patients with sepsis
There is a negative correlation
between LFnu, LF/HF and CRP, IL-6,
IL-10, SOFA score
Tiainen 2009 Assess if HRV changes (and has
prognostic ability) with therapeutic
cooling of resuscitated cardiac arrest
patients
Higher SDNN, SDANN, TP, LF, HF in
the first 48 h of cooling. SDNN
>100 ms predicts better neurological
outcome
Schmidt 2010 To assess if ACE-I therapy affects short
(28-day) and long (365-day) mortality
in patients with MODS
ACE-I associated with preserved VLF,
LF, HF, TP and survival (28-day and
365-day)
Kasaoka 2010 To trial a real-time HRV measurement
and analysis system
LF, HF and LF/HF higher in patients
spontaneously breathing compared
to mechanical ventilation
Chen 2012 To compare HRV between
post-resuscitation cardiac arrest patients
and patients with severe sepsis
No significant differences in HRV
indices between OOHCA and Severe
Sepsis patients
Low LF, LFnu, LF/HF associated with
mortality
Gomez Duque 2012 To investigate the incidence of
cardiovascular adverse events in
patients with sepsis
Deceased patients demonstrated
lower SDNN than survivors
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Pharmacologic and clinical interventions
Studies varied in their exclusion criteria and reporting of potential confounding factors
including age, gender, body mass index [59], common comorbidities [60–63], drug
therapy [64–68] and/or ICU interventions (Tables 4 and 5). Exclusion criteria used and
comorbidities/drugs are summarised in Additional file 1. A minority of studies (12;
39%) excluded patients with chronic comorbidities that are commonly associated with
autonomic dysfunction. Reporting of drugs that directly affect autonomic function was
highly variable across studies. A majority of studies (25; 81%) did not detail drug ther-
apy. Around 22% studies did not report the use of mechanical ventilation, and more
than 25% failed to report whether sedation and/or vasoactive drugs were used at the
time of HRV recordings.
Table 2 Study objectives and key findings (Continued)
Brown 2013 Assess if HRV can predict vasopressor
dependence at 24 h in sepsis
Traditional HRV indices not associated
with vasopressor requirement after
controlling for HR
Green 2013 Association of HRV and illness severity
in MODS
Low LFnu and LF/HF associated with
increased MODS
Wieske 2013 Relationship between autonomic
dysfunction (HRV) and ICU-acquired
weakness
Artefacts, mechanical ventilation,
sedation, catecholamines and heart
rate all associated with TP
% artefacts were associated with TP
and LF/HF
No association between HRV and
ICU-acquired weakness
Wieske 2013 Compare different autonomic function
tests in critically unwell patients
(CFT, SWT and HRV)
Only HRV tests associated with
SOFA score
Bradley 2013 Impact of sedation and sedation
interruptions on HRV
SDNN, RMSSD and HF all increased
during sedation interruption (more
pronounced in less unwell patients)
Huang 2014 Assess if HRV associated with weaning
success or failure
Reduction in TP during SBT
associated with failure
Tang 2014 Assess if HRV predicts outcome in ICU
stroke patients
Traditional HRV indices were unable
to predict outcome
Zhang 2014 Asses if HRV can predict infected
pancreatic necrosis or MODS in patients
with severe acute pancreatitis
Low LFnu, LF/HF and high HFnu
associated with increased MODS
and mortality
Schmidt 2014 Assess relationship between HRV and
illness severity in CCF and MODS
MODS patients demonstrated lower
HRV indices in all parameters
compared to CCF patients.
Zaal 2015 To assess if HRV is abnormal in patients
with ICU delirium.
No association between HRV and
delirium found
Hammash 2015 Assess relationship between HRV and
incidence of dysrhythmias during
weaning
LF was higher during spontaneous
breathing than during controlled
mechanical ventilation.
Nagaraj 2016 Assess if sedation levels can be
classified by HRV algorithms
Algorithms using composite
measures of HRV may discriminate
between levels of sedation in ICU
patients
ACE-I angiotensin-converting enzyme inhibitor, CCF congestive cardiac failure, CFT cold face test, CRP C-reactive
protein, HF high frequency, HFnu high frequency normalised unit, HRV heart rate variability, IL-6 interleukin 6,
IL-10 interleukin 10, LF low frequency, LFnu low frequency normalised unit, MODS multiple organ dysfunction,
RMSSD root mean square of successive differences, SOFA sequential organ failure assessment, SBT spontaneous
breathing trial, SWT skin wrinkle test, TP total power, VLF very low frequency, LnVLF natural logarithm of very
low frequency
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Discussion
This review is the first to systematically explore how HRV analyses are undertaken
and/or reported in critically ill patients. Despite a wealth of laboratory and translational
data suggesting that HRV may offer diagnostic and prognostic utility, significant het-
erogeneity in methodology between HRV articles precluded comparisons across studies
and meta-analysis. Our review identifies several areas that require greater scrutiny in
future, highlighting the need to develop consensus guidelines that are relevant and
tailor-made for the challenges faced by researchers in critical care medicine.
Well-recognised technical, physiologic and clinical factors impact on the measure-
ment, and interpretation of HRV [69, 70]. We found highly variable practice in three
key technical areas. Low sampling rates (<250 Hz) impair the precise detection of the R
wave fiducial point in the ECG waveform, which consequently affects the power
spectrum [15]. This is particularly relevant for studies that derived R–R intervals from
arterial pressure waveform analysis [20, 47], since non-neural respiratory influences
(e.g. changes in ventricular mechanics) differentially affect mechanical pulse waves and
electrical R waves [55]. Manual inspection of the raw ECG to identify artefact is pre-
ferred to automated methods to avoid the introduction of false frequency components
into the power spectrum [57]. The variable (or unstated) masking of HRV analysers to
clinical data also introduces potential significant bias.
From a physiologic perspective, reporting and/or adjustment for heart rate and re-
spiratory rate was inconsistent between studies, with heart rate frequently not reported.
Across species with highly variable heart rates, HRV appears to be largely attributable
to incident heart rate. If heart rate is not taken into account, erroneous conclusions re-
garding HRV are likely since differences may merely reflect lower heart rate [12]. This
is particularly of relevance to hemodynamically unstable critically ill patients, in whom
heart rate may rapidly change. Similarly, increases in respiratory frequency and tidal
volume affect both high and low frequency spectral components [58]. Hence, standar-
dised criteria for ventilatory and heart rate reporting are required for the interpretation
of HRV data between studies (and hence, potentially, meta-analysis).
From a clinical perspective, HRV parameters are influenced strongly by age, gender,
functional capacity and chronic comorbidities. Whilst all studies estimated severity of
Fig. 1 Forest plot of individual effect sizes (Cohen’s d) across six studies investigating the relationship
between LF/HF ratio and disease severity and mortality
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Table 3 Procedures for measurement, processing and reporting of HRV








Annane 1999 5 min/–/– PRV 500 Interpolation TP, LF, HF, LF/HF, Lfnu, Hfnu
Korach 2001 30 min supine/0800–1200 ECG 5 Interpolation Lfnu, Hfnu, LF/HF
Barnaby 2002 5 min/–/– ECG – Interpolation TP, LF, HF, Lfnu, Hfnu, LF/HF
Pontet 2003 10 min/supine/2100–2300 ECG >500 Interpolation SDNN, RMSSD, LF, HF, Lfnu,
Hfnu, LF/HF
Shen 2003 90 min/semi recumbent/
1000–1400
ECG – Interpolation TP, LnLF, LnHF, Lfnu, Hfnu,
LF/HF
Schmidt 2005 24 hours ECG 256 Interpolation SDNN, SDANN, RMSSD,
pNN50, VLF, LF, HF, LF/HF
Papaioannou 2006 10 min/supine/morning ECG 250 Segment
selection
LF/HF
Bourgault 2006 20 min/–/day and night ECG 1000 – LF, HF, LF/HF, TP
Chen 2007 10 min/supine/day and
night
ECG – Interpolation RMSSD, TP, LF, HF, Lfnu,
Hfnu, LF/HF
Passariello 2007 24 h ECG – – SDNN, SDANN, pNN50,
RMSSD
Chen 2008 10 min/supine/day and
night
ECG – Interpolation SDNN, RMSSD, TP, LF, HF,
Lfnu, Hfnu, LF/HF
Aboab 2008 5 min/supine/– PRV – Interpolation TP, Lfnu, Hfnu, LF/HF
Nogueira 2008 30 min/supine/morning ECG – – LF, HF, LF/HF
Papaioannou 2009 10 min/–/– ECG 250 Segment
selection
SDNN, Lfnu, Hfnu, LF/HF
Tiainen 2009 24 h ECG – – SDNN, SDANN, TP, LF, HF,
Schmidt 2010 24 h ECG 256 Interpolation LnTP, LnVLF, LnHF, LnLF,
LF/HF
Kasaoka 2010 5 min/supine/– ECG – – LnLF, LnHF, LF/HF
Chen 2012 10 min/supine/day and
night
ECG – Interpolation SDNN, TP, VLF, LF, HF, Hfnu,
Lfnu, LF/HF
Gomez Duque 2012 24 h ECG – – SDNN, PNN50
Brown 2013 6 h/–/– ECG 500 Deletion SDNN, pNN50, Lfnu, Hfnu,
LF/HF
Green 2013 24 h ECG 125 Deletion SDNN, RMSSD, Lfnu, Hfnu,
LF/HF
Wieske 2013 5 min/–/– ECG 250 Interpolation HR, TP, LF/HF
Wieske 2013 5 min/supine/– ECG 250 Deletion LF, HF, Lfnu, Hfnu, LF/HF
Bradley 2013 24 h ECG 125 Deletion SDNN, RMSSD, LF, HF, LF/HF
Huang 2014 5 min/semi-recumbent/
0800–1200
ECG – – LnTP, LnVLF, Hfnu, Lfnu,
LF/HF
Tang 2014 60 min/–/– ECH 512 – SDNN, RMSSD, LF, HF, LF/HF
Zhang 2014 5 min/–/0900–1100 ECG – Deletion SDNN, RMSSD, TP, VLF, LF,
HF, Lfnu, Hfnu, LF/HF
Schmidt 2014 24 h ECG 256 Interpolation SDNN, SDANN, SDNNi,
RMSSD, pNN50, VLF, LF, HF,
LnLF, LnHF, LF/HF
Zaal 2015 15 min/supine, 0800–1700 ECG 500 Segment
selection
LnLF, LnHF, Hfnu, LF/HF
Hammash 2015 24 h ECG – Interpolation VLF, HF, LF
Nagaraj 2016 24 h (5 min epochs) ECG 240 Thresholding SDNN, RMSSD, VLF, LF, HF,
LF/HF, LFnu, HFnu
ECG electrocardiogram, HF high frequency, HFnu high frequency normalised unit, LF low frequency, LFnu low
frequency normalised unit, Ln natural logarithm, pNN50 percentage of normal–normal intervals >50 ms, PRV pulse
rate variability, RMSSD root mean square of successive differences, SDANN standard deviation of average normal–
normal intervals, SDNN standard deviation of normal–normal intervals, TP total power
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illness, the most frequently employed—Acute Physiology and Chronic Health
Evaluation II (APACHE-II)—are limited in capturing information about chronic comor-
bid disease that are over-represented in the critical care medicine population. For ex-
ample, diabetes mellitus, a common condition associated with cardiac autonomic
neuropathy, is not captured by this type of assessment [60]. Typically, chronic condi-
tions at the severe end of the disease spectrum are included (e.g. APACHE-II score only
includes severe heart failure (≥NYHA class 3). However, HRV parameters have been
found to be abnormal in early cases of chronic disease, including preserved ejection
fraction, coronary artery disease, chronic kidney disease and hypertension [60–63].
Although some studies have considered these factors, serial measures or dynamic auto-
nomic challenges offer a potentially more insightful and individualised approach to
Table 4 Reporting of potential clinical confounders









Annane 1999 Excluded – 100% 0% 0% – HR/RR
Korach 2001 – – 41.5%. 19.5% 12.20% – –
Barnaby 2002 – – 0% – 0% – HR/RR
Pontet 2003 Excluded Excluded 38.5% – 17.90% – HR
Shen 2003 + + 100% 0% 0% – HR/RR
Schmidt 2005 – – 71% 61% 62% – –
Papaioannou 2006 + – – + – – –
Bourgault 2006 Excluded Excluded 100% 33% 0% – HR
Chen 2007 Excluded/+ – – – 0% – HR/RR
Passriello 2007 + + – – – – HR
Chen 2008 + – 0% – – – HR
Aboab 2008 Excluded – 100% 80.9% 100% – HR
Nogueira 2008 Excluded – 100% – 100% – RR
Papaioannou 2009 – Excluded 100% 100% – – –
Tiainen 2009 + – 100% 100% 87% – HR
Schmidt 0 2010 + – 88% 89% 74% – –
Kasaoka 1 2010 – – 100% 100% – – –
Chen 2012 + – OHCA 100%,
SS + MV 100%,
SS 0%, S 0%
OHCA 81,
SS + MV 63%,
SS 59%, S 0%
OHCA 100%,
SS + MV 9%,
SS 18.8%, S 0%
– HR
Gomez Duque 2012 Excluded/+ – – – 72% – –
Brown 2013 – – – – 63% – HR
Green 2013 – – 90.90% + 78.80% – HR
Wieske 2013 Excluded/+ + + + + – HR
Wieske 2013 Excluded/+ – 100% – – – –
Bradley 2013 – – + + + – HR
Huang 2014 Excluded/+ Excluded/+ 100% – – – RR
Zhang 2014 – – – – 12% – –
Schmidt 2014 – + 89.2% 72.3% 72.3% – HR
Tang 2014 + + – – – – HR
Zaal 2015 Excluded Excluded 60% 20% 0% – –
Hammash 2015 Excluded/+ – 100% – – – –
Nagaraj 2016 – – 100% 100% – – HR
Excluded refers to specific comorbidities or drugs were part of exclusion criteria of study
HR heart rate, RR respiratory rate, + reported but proportion of patients not provided, – not reported
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assessing HRV. Novel HRV parameters that can be captured within the first few mi-
nutes of critical illness, such as deceleration capacity of heart rate [71], may mitigate
the need for refining the use of more traditional time and frequency domain measures.
For mechanistic studies investigating whether changes in autonomic parameters correl-
ate with, or precede, pathologic events, targeting clinical scenarios where multiple,
complementary baseline autonomic measures [72, 73] can be made before critical ill-
ness develops may be optimal [74]. Studies where basal autonomic function can be cap-
tured, including elective surgery [73–76] and oncologic sepsis [48, 49], may provide
particularly powerful mechanistic insights since autonomic changes can be individua-
lised and referenced to pre-insult normal, or pre-existing, dysfunction. Several studies
have highlighted that HRV values in critical care medicine are similar to those found in
Table 5 Reporting of potential confounders









Annane [17] 1999 Excluded – 100% 0% 0% – HR/RR
Korach [18] 2001 – – 41.5%. 19.5% 12.20% – –
Barnaby [19] 2002 – – 0% – 0% – HR/RR
Pontet [20] 2003 Excluded Excluded 38.5% – 17.90% – HR
Shen [21] 2003 + + 100% 0% 0% – HR/RR
Schmidt [22] 2005 – – 71% 61% 62% – –
Papaioannou [23] 2006 + – – + – – –
Bourgault [24] 2006 Excluded Excluded 100% 33% 0% – HR
Chen [25] 2007 Excluded/+ – – – 0% – HR/RR
Passriello 2007 + + – – – – HR
Chen [26] 2008 + – 0% – – – HR
Aboab [27] 2008 Excluded – 100% 80.9% 100% – HR
Nogueira [28] 2008 Excluded – 100% – 100% – RR
Papaioannou [29] 2009 – Excluded 100% 100% – – –
Tiainen 2009 + – 100% 100% 87% – HR
Schmidt [30] 2010 + – 88% 89% 74% – –
Kasaoka [31] 2010 – – 100% 100% – – –
Chen [32] 2012 + – OHCA 100%,
SS + MV 100%,
SS 0%, S 0%
OHCA 81,
SS + MV 63%,
SS 59%, S 0%
OHCA 100%,
SS + MV 9%,
SS 18.8%, S 0%
– HR
Gomez Duque [33] 2012 Excluded/+ – – – 72% – –
Brown [34] 2013 – – – – 63% – HR
Green [35] 2013 – – 90.90% + 78.80% – HR
Wieske [36] 2013 Excluded/+ + + + + – HR
Wieske [37] 2013 Excluded/+ – 100% – – – –
Bradley [38] 2013 – – + + + – HR
Huang [39] 2014 Excluded/+ Excluded/+ 100% – – – RR
Zhang [40] 2014 – – – – 12% – –
Schmidt [41] 2014 – + 89.2% 72.3% 72.3% – HR
Tang 2014 + + – – – – HR
Zaal [42] 2015 Excluded Excluded 60% 20% 0% – –
Hammash [43] 2015 Excluded/+ – 100% – – – –
Nagaraj 2016 – – 100% 100% – – HR
Excluded refers to specific comorbidities or drugs were part of exclusion criteria of study
HR heart rate, RR respiratory rate, + reported but proportion of patients not provided, – not reported
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common cardiovascular pathologic conditions [74, 75, 77]; this highlights the need for
individualised patient data in order to rule out that autonomic dysfunction is not a pre-
cursor of critical illness, rather than merely a biomarker.
Commonly used anti-arrhythmic drugs, anti-hypertensive drugs, statins, metformin
and inhaled bronchodilators have all been associated with changes in HRV parameters
[60–63]. However, the lack of reporting on medications that critically ill patients re-
ceived reduces the mechanistic insight afforded by this approach, particularly given the
strong correlation between HRV and morbidity/mortality appears to be largely attribut-
able to incident heart rate. Similarly, the majority of studies in this review failed to con-
sistently report on the use of common critical care interventions. This may explain why
conflicting conclusions over how variety of features of critical illness may affect HRV.
Continuous enteral or parenteral nutrition are both associated with a reduction in time
domain HRV measures indicative of parasympathetic cardiac modulation [67]. How-
ever, we did not find any studies that reported on the feeding or fasting status of pa-
tients. Although a significant limitation of our study was the lack of primary source
data, in any event, we could not identify a single common HRV parameter measured in
all studies that enabled comparison. A further limitation is that we did not consider
newer nonlinear and multiscale approaches, since very few studies incorporating these
analyses have been undertaken. These approaches are also likely to be affected by the
same factors that influence traditional HRV parameters [78]. Thus, in a clinical setting,
further work is required to establish whether these newer approaches reduce the im-
pact of several confounding factors we have identified in this review.
Conclusions
Heart rate and derived heart rate variability offers a non-invasive, inexpensive tool that
may add mechanistic insights to our understanding of critical illness and also assist
clinical care. However, the current interpretation of generalizable and clinically relevant
values to aid clinical decisions/research is hampered by a non-standardised methodolo-
gic approach and lack of adjustment for important confounding factors. For critical
care medicine to exploit recent advances in translational autonomic physiology, further
high-quality prospective HRV studies underpinned by the development of consensus
reporting standards relevant for critical care medicine are needed.
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